Skip to main content

Narcís Saubí Roca

I am a Biochemist, and I am in the Microbiology department, in the Respiratory Virus Unit, working on the isolation in cell cultures and phenotypic characterization of different respiratory viruses (Influenza, RSV, hMPV, enterovirus). I am also collaborating with other HUVH and VHIR research groups that require the growth of viruses in cultures. Previously, I was working on the development of preventive vaccines against HIV (one based on Bacillus Calmette-Guerin (BCG), and the other based on Virus-Like particles -VLP- of the human papillomavirus) and SARS - CoV-2.

Institutions of which they are part

Senior researcher
Microbiology
Vall Hebron Institut de Recerca

Narcís Saubí Roca

Institutions of which they are part

Senior researcher
Microbiology
Vall Hebron Institut de Recerca

I am a Biochemist, and I am in the Microbiology department, in the Respiratory Virus Unit, working on the isolation in cell cultures and phenotypic characterization of different respiratory viruses (Influenza, RSV, hMPV, enterovirus). I am also collaborating with other HUVH and VHIR research groups that require the growth of viruses in cultures. Previously, I was working on the development of preventive vaccines against HIV (one based on Bacillus Calmette-Guerin (BCG), and the other based on Virus-Like particles -VLP- of the human papillomavirus) and SARS - CoV-2.

In December 2021, I joined the Respiratory Virus Unit at the Microbiology Department, with Dr. Andrés Antón, to perform isolation and phenotypic characterization of respiratory viruses (Influenza, RSV, hMPV, enterovirus). It is also among my roles to support other VHIR and HUVH groups.
Previously, I had been working on the development of preventive vaccines against HIV and SARS-CoV-2. The vaccines were based on the use of Bacillus Calmette-Guérin (BCG) as a vaccine vector, and on the use of chimeric VLPs (Virus Like Particles) of the Human Papilloma Virus that expressed HIV or SARS-CoV-2 epitopes. I started this research in 2005, at the Infectious Diseases and HIV Group of the Hospital Clínic de Barcelona, with Dr. Joan Joseph. This was the subject of my doctoral thesis. In 2019, the entire research group moved to the Microbiology Department of Vall d’Hebron University Hospital.
I started my career in vaccine research and development at Laboratorios Hipra, S.A., where I worked for 13 years on vaccines against avian, porcine and bovine virus research, development and manufacture.

Projects

European AIDS Vaccine Initiative 2020 (EAVI2020)

IP: Joan Joseph Munné
Collaborators: Narcís Saubí Roca
Funding agency: EUROPEAN COMMISSION
Funding: 195142.58
Reference: EAVI_H2020
Duration: 01/06/2019 - 31/12/2022

Related news

The new diagnostic method, designed for use in endemic regions, combines a mobile application with a low-cost robotic microscope.

The European network EUPertStrain celebrates its annual meeting, focused on the study of the evolution of Bordetella pertussis, the bacterium responsible for this disease that can be very serious in children under one year.

The Vall d'Hebron work has shown that people vaccinated with Pfizer or Moderna have specific memory T lymphocytes against SARS-CoV-2 in the lung months after vaccination.

Related professionals

Concepción Gomez Gavara

Concepción Gomez Gavara

Main researcher
Hepato-bilio-pancreatic surgery (HBP) and liver transplantation
Read more
José vicente Andres Peiro

José vicente Andres Peiro

Reconstructive Surgery of the Locomotor System
Read more
Sheila Garcia  Prado

Sheila Garcia Prado

Psychiatry, Mental Health and Addictions
Read more
Irene Hernández Hernández

Irene Hernández Hernández

Predoctoral researcher
Diabetes and Metabolism
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.